I went back to look at their historical cash burn - it's been steady at $4-5m every quarter except this one.
I'm not sure if this quarter's $8.5m is unusually high, or on par for a company moving into clinical. Perhaps someone with more knowledge can advise.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-21
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.33 |
Change
0.080(6.43%) |
Mkt cap ! $772.8M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.35 | $1.21 | $763.8K | 595.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 97719 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.33 | 6599 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |